Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanshuo Chu

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cancer Discovery|September 13, 2022
The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung AdenocarcinomaDapeng Hao, Guangchun Han, Ansam Sinjab, et al.
Cancer Cell|June 13, 2023
Single cell clonotypic and transcriptional evolution of multiple myeloma precursor diseaseMinghao Dang, Ruiping Wang, Hans C Lee, et al.
Gastroenterology|August 3, 2024
Atlas of Metastatic Gastric Cancer Links Ferroptosis to Disease Progression and Immunotherapy ResponseXiangdong Cheng, Enyu Dai, Jibo Wu, et al.
Cancer Cell|July 7, 2023
Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progressionRuiping Wang, Shumei Song, Jiangjiang Qin, et al.
Nature Communications|April 13, 2022
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapySang T Kim, Yanshuo Chu, Mercy Misoi, et al.
Science Advances|March 13, 2024
Clonal dominance defines metastatic dissemination in pancreatic cancerI-Lin Ho, Chieh-Yuan Li, Fuchenchu Wang, et al.
Nature Medicine|May 29, 2023
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistanceYanshuo Chu, Enyu Dai, Yating Li, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
WRAD core perturbation impairs DNA replication fidelity promoting immunoediting in pancreatic cancerFrancesca Citron, I-Lin Ho, Chiara Balestrieri, et al.
Nature Communications|November 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidenceMelinda Soeung, Xinmiao Yan, Ciro Zanca, et al.
Nature|June 15, 2022
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapyChristopher P Vellano, Michael G White, Miles C Andrews, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer Discovery|September 13, 2022
The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung AdenocarcinomaDapeng Hao, Guangchun Han, Ansam Sinjab, et al.
Cancer Cell|June 13, 2023
Single cell clonotypic and transcriptional evolution of multiple myeloma precursor diseaseMinghao Dang, Ruiping Wang, Hans C Lee, et al.
Gastroenterology|August 3, 2024
Atlas of Metastatic Gastric Cancer Links Ferroptosis to Disease Progression and Immunotherapy ResponseXiangdong Cheng, Enyu Dai, Jibo Wu, et al.
Cancer Cell|July 7, 2023
Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progressionRuiping Wang, Shumei Song, Jiangjiang Qin, et al.
Nature Communications|April 13, 2022
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapySang T Kim, Yanshuo Chu, Mercy Misoi, et al.
Science Advances|March 13, 2024
Clonal dominance defines metastatic dissemination in pancreatic cancerI-Lin Ho, Chieh-Yuan Li, Fuchenchu Wang, et al.
Nature Medicine|May 29, 2023
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistanceYanshuo Chu, Enyu Dai, Yating Li, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
WRAD core perturbation impairs DNA replication fidelity promoting immunoediting in pancreatic cancerFrancesca Citron, I-Lin Ho, Chiara Balestrieri, et al.
Nature Communications|November 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidenceMelinda Soeung, Xinmiao Yan, Ciro Zanca, et al.
Nature|June 15, 2022
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapyChristopher P Vellano, Michael G White, Miles C Andrews, et al.
Pageof 2